Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Draper

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
A comparative study of tuberculosis patients initiated on ART and receiving different models of TB-HIV careS A Schulz, H R Draper, P Naidoo
Public Health Action|September 25, 2015
Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South AfricaE Elliott, H R Draper, P Baitsiwe, et al.
Public Health Action|March 28, 2018
What drives 'first-time testers' to test for HIV at community-based HIV testing services?S-A Meehan, H R Draper, R Burger, et al.
Public Health Action|September 25, 2015
Factors influencing increased expertise for a sustainable workforce at a research centre in South AfricaS Brand, H R Draper, D A Enarson, et al.
International Journal of STD & AIDS|August 24, 2013
Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in SwazilandE J Dziuban, S A Marton, A B Hughey, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Pharmacokinetics of isoniazid in low-birth-weight and premature infantsA Bekker, H S Schaaf, H I Seifart, et al.
IJTLD Open|July 5, 2024
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatmentD T Wademan, H R Draper, S E Purchase, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2016
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in childrenA J Garcia-Prats, L du Plessis, H R Draper, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment GuidelinesA Bekker, H S Schaaf, H R Draper, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2014
Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in childrenS Thee, A J Garcia-Prats, H M McIlleron, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
A comparative study of tuberculosis patients initiated on ART and receiving different models of TB-HIV careS A Schulz, H R Draper, P Naidoo
Public Health Action|September 25, 2015
Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South AfricaE Elliott, H R Draper, P Baitsiwe, et al.
Public Health Action|March 28, 2018
What drives 'first-time testers' to test for HIV at community-based HIV testing services?S-A Meehan, H R Draper, R Burger, et al.
Public Health Action|September 25, 2015
Factors influencing increased expertise for a sustainable workforce at a research centre in South AfricaS Brand, H R Draper, D A Enarson, et al.
International Journal of STD & AIDS|August 24, 2013
Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in SwazilandE J Dziuban, S A Marton, A B Hughey, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2014
Pharmacokinetics of isoniazid in low-birth-weight and premature infantsA Bekker, H S Schaaf, H I Seifart, et al.
IJTLD Open|July 5, 2024
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatmentD T Wademan, H R Draper, S E Purchase, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2016
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in childrenA J Garcia-Prats, L du Plessis, H R Draper, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment GuidelinesA Bekker, H S Schaaf, H R Draper, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2014
Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in childrenS Thee, A J Garcia-Prats, H M McIlleron, et al.
Pageof 2